Literature DB >> 21191086

Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2.

Susu M Zughaier1.   

Abstract

CPS are major virulence factors in infections caused by Neisseria meningitidis and form the basis for meningococcal serogroup designation and protective meningococcal vaccines. CPS polymers are anchored in the meningococcal outer membrane through a 1,2-diacylglycerol moiety, but the innate immunostimulatory activity of CPS is largely unexplored. Well-established human and murine macrophage cell lines and HEK/TLR stably transfected cells were stimulated with CPS, purified from an endotoxin-deficient meningococcal serogroup B NMB-lpxA mutant. CPS induced inflammatory responses via TLR2- and TLR4-MD-2. Meningococcal CPS induced a dose-dependent release of cytokines (TNF-α, IL-6, IL-8, and CXCL10) and NO from human and murine macrophages, respectively. CPS induced IL-8 release from HEK cells stably transfected with TLR2/6, TLR2, TLR2/CD14, and TLR4/MD-2/CD14 but not HEK cells alone. mAb to TLR2 but not an isotype control antibody blocked CPS-induced IL-8 release from HEK-TLR2/6-transfected cells. A significant reduction in TNF-α and IL-8 release was seen when THP-1- and HEK-TLR4/MD-2-CD14- but not HEK-TLR2- or HEK-TLR2/6-transfected cells were stimulated with CPS in the presence of Eritoran (E5564), a lipid A antagonist that binds to MD-2, and a similar reduction in NO and TNF-α release was also seen in RAW 264.7 cells in the presence of Eritoran. CD14 and LBP enhanced CPS bioactivity, and NF-κB was, as anticipated, the major signaling pathway. Thus, these data suggest that innate immune recognition of meningococcal CPS by macrophages can occur via TLR2- and TLR4-MD-2 pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191086      PMCID: PMC3040465          DOI: 10.1189/jlb.0610369

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  62 in total

1.  Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14.

Authors:  Can Kocabas; Nora Katsenelson; Sunita Kanswal; Margaret N Kennedy; Xinle Cui; Milan S Blake; David M Segal; Mustafa Akkoyunlu
Journal:  Cell Microbiol       Date:  2007-01-22       Impact factor: 3.715

2.  Two modes of ligand recognition by TLRs.

Authors:  Igor Brodsky; Ruslan Medzhitov
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

3.  Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa.

Authors:  Umeharu Ohto; Koichi Fukase; Kensuke Miyake; Yoshinori Satow
Journal:  Science       Date:  2007-06-15       Impact factor: 47.728

Review 4.  Surfactant collectins and innate immunity.

Authors:  Henk P Haagsman; Astrid Hogenkamp; Martin van Eijk; Edwin J A Veldhuizen
Journal:  Neonatology       Date:  2008-06-05       Impact factor: 4.035

5.  Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.

Authors:  Ho Min Kim; Beom Seok Park; Jung-In Kim; Sung Eun Kim; Judong Lee; Se Cheol Oh; Purevjav Enkhbayar; Norio Matsushima; Hayyoung Lee; Ook Joon Yoo; Jie-Oh Lee
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

Review 6.  Modulation of host immune responses by helminth glycans.

Authors:  Donald A Harn; Jasmine McDonald; Olga Atochina; Akram A Da'dara
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

7.  Identification of genes particularly sensitive to lipopolysaccharide (LPS) in human monocytes induced by wild-type versus LPS-deficient Neisseria meningitidis strains.

Authors:  Reidun Ovstebø; Ole Kristoffer Olstad; Berit Brusletto; Anne Sophie Møller; Audun Aase; Kari Bente Foss Haug; Petter Brandtzaeg; Peter Kierulf
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

8.  Pneumococcal capsular polysaccharide is immunogenic when present on the surface of macrophages and dendritic cells: TLR4 signaling induced by a conjugate vaccine or by lipopolysaccharide is conducive.

Authors:  Noam Cohen; Michal Stolarsky-Bennun; Hila Amir-Kroll; Raanan Margalit; Gabriel Nussbaum; Michal Cohen-Sfady; Meirav Pevsner-Fischer; Mati Fridkin; Herve Bercovier; Lea Eisenbach; Steffen Jung; Irun R Cohen
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

9.  Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4.

Authors:  Shanta M Zimmer; Susu M Zughaier; Yih-Ling Tzeng; David S Stephens
Journal:  Glycobiology       Date:  2007-06-02       Impact factor: 4.313

Review 10.  Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.

Authors:  David S Stephens; Brian Greenwood; Petter Brandtzaeg
Journal:  Lancet       Date:  2007-06-30       Impact factor: 79.321

View more
  28 in total

1.  Induction of death receptor CD95 and co-stimulatory molecules CD80 and CD86 by meningococcal capsular polysaccharide-loaded vaccine nanoparticles.

Authors:  Ruhi V Ubale; Rikhav P Gala; Susu M Zughaier; Martin J D'Souza
Journal:  AAPS J       Date:  2014-07-01       Impact factor: 4.009

2.  MD-2 is involved in the stimulation of matrix metalloproteinase-1 expression by interferon-γ and high glucose in mononuclear cells - a potential role of MD-2 in Toll-like receptor 4-independent signalling.

Authors:  Zhongyang Lu; Yanchun Li; Devadoss J Samuvel; Junfei Jin; Xiaoming Zhang; Maria F Lopes-Virella; Yan Huang
Journal:  Immunology       Date:  2013-11       Impact factor: 7.397

Review 3.  The role of Toll-like receptor 4 polymorphisms in vaccine immune response.

Authors:  P Pellegrino; F S Falvella; S Cheli; C Perrotta; E Clementi; S Radice
Journal:  Pharmacogenomics J       Date:  2015-03-31       Impact factor: 3.550

4.  Effect of TNF-α inhibitors on transcriptional levels of pro-inflammatory interleukin-33 and Toll-like receptors-2 and -9 in psoriatic plaques.

Authors:  Dimitra P Vageli; Aikaterini Exarchou; Efterpi Zafiriou; Panagiotis G Doukas; Sotirios Doukas; Angeliki Roussaki-Schulze
Journal:  Exp Ther Med       Date:  2015-08-18       Impact factor: 2.447

5.  Antibody response specific to the capsular polysaccharide is impaired in Streptococcus suis serotype 2-infected animals.

Authors:  Cynthia Calzas; Paul Lemire; Gael Auray; Volker Gerdts; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

6.  Analysis of novel meningococcal vaccine formulations.

Authors:  Susu M Zughaier
Journal:  Hum Vaccin Immunother       Date:  2017-04-10       Impact factor: 3.452

7.  Group B Streptococcus and Streptococcus suis capsular polysaccharides induce chemokine production by dendritic cells via Toll-like receptor 2- and MyD88-dependent and -independent pathways.

Authors:  Cynthia Calzas; Guillaume Goyette-Desjardins; Paul Lemire; Fleur Gagnon; Claude Lachance; Marie-Rose Van Calsteren; Mariela Segura
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

8.  TLR2 and TLR4 mediate the TNFα response to Vibrio vulnificus biotype 1.

Authors:  Lola V Stamm; Rebecca L Drapp
Journal:  Pathog Dis       Date:  2014-03-06       Impact factor: 3.166

9.  The meningococcal adhesin NhhA provokes proinflammatory responses in macrophages via toll-like receptor 4-dependent and -independent pathways.

Authors:  Mikael Sjölinder; Georg Altenbacher; Xiao Wang; Yumin Gao; Charlotta Hansson; Hong Sjölinder
Journal:  Infect Immun       Date:  2012-09-04       Impact factor: 3.441

10.  A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side.

Authors:  Stefanie Dinner; Julia Borkowski; Carolin Stump-Guthier; Hiroshi Ishikawa; Tobias Tenenbaum; Horst Schroten; Christian Schwerk
Journal:  J Vis Exp       Date:  2016-05-06       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.